-
Needham & Company LLC Reiterates Buy Rating for CRISPR Therapeutics (NASDAQ:CRSP)
来源: Buzz FX / 06 11月 2024 07:48:16 America/Chicago
Needham & Company LLC Reiterates Buy Rating for CRISPR Therapeutics (NASDAQ:CRSP) Written by MarketBeat November 6, 2024 Share Link copied to clipboard. CRISPR Therapeutics ( NASDAQ:CRSP - Get Free Report ) 's stock had its "buy" rating res
Read more...